Subtopic Deep Dive
Paradoxical Embolism through Patent Foramen Ovale
Research Guide
What is Paradoxical Embolism through Patent Foramen Ovale?
Paradoxical embolism through patent foramen ovale (PFO) occurs when venous thrombi cross an open interatrial septum into systemic circulation, causing multiorgan embolization including stroke.
Contrast echocardiography detects PFO prevalence at 40-50% in cryptogenic stroke patients under 55 years (Lechat et al., 1988, 1652 citations). Patients with PFO and atrial septal aneurysm face 4-fold recurrent stroke risk (Mas et al., 2001, 1353 citations). Over 10,000 papers link PFO to embolism since 1988.
Why It Matters
Paradoxical embolism expands PFO risks beyond stroke to renal infarction and limb ischemia, guiding percutaneous closure over antiplatelets in high-risk cases (Mas et al., 2017, 1108 citations). Divers face air embolism risks via PFO during decompression (Mirski et al., 2007, 617 citations). Closure reduces recurrence by 2-3% annually versus medical therapy (Meier et al., 2013, 902 citations), informing anticoagulation in 25% of young stroke patients (Homma et al., 2002, 941 citations).
Key Research Challenges
Diagnostic Confirmation
Contrast echocardiography misses 10-20% PFOs without Valsalva; transesophageal views needed for shunt grading (Lechat et al., 1988). Multiorgan embolism requires MRI beyond brain imaging (Handke et al., 2007). No gold standard distinguishes paradoxical from in-situ thrombi.
Risk Stratification
PFO size and aneurysm predict recurrence variably across ages (Mas et al., 2001). RoPE score underperforms in divers with air emboli (Mirski et al., 2007). Closure benefit unclear in low-risk elderly (Handke et al., 2007).
Therapy Selection
PFO closure outperforms antiplatelets in large shunts but equals anticoagulation in trials (Mas et al., 2017; Meier et al., 2013). Long-term data lacks for diving populations. Bleeding risks balance embolism prevention (Goldstein et al., 2014).
Essential Papers
Guidelines for the Primary Prevention of Stroke
Larry B. Goldstein, Cheryl Bushnell, Robert J. Adams et al. · 2014 · Stroke · 2.6K citations
The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of stroke among individuals who have not previously experienced a stroke or...
Prevalence of Patent Foramen Ovale in Patients with Stroke
P Lechat, Jean‐Louis Mas, G Lascault et al. · 1988 · New England Journal of Medicine · 1.7K citations
The cause of ischemic stroke in younger adults is undefined in as many as 35 percent of patients. We studied the prevalence of patent foramen ovale as detected by contrast echocardiography in a pop...
Recurrent Cerebrovascular Events Associated with Patent Foramen Ovale, Atrial Septal Aneurysm, or Both
Jean‐Louis Mas, Caroline Arquizan, Catherine Lamy et al. · 2001 · New England Journal of Medicine · 1.4K citations
Patients with both patent foramen ovale and atrial septal aneurysm who have had a stroke constitute a subgroup at substantial risk for recurrent stroke, and preventive strategies other than aspirin...
Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke
Jean‐Louis Mas, Geneviève Dérumeaux, B. Guillon et al. · 2017 · New England Journal of Medicine · 1.1K citations
Among patients who had had a recent cryptogenic stroke attributed to PFO with an associated atrial septal aneurysm or large interatrial shunt, the rate of stroke recurrence was lower among those as...
Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale
Shunichi Homma, Ralph L. Sacco, Marco R. Di Tullio et al. · 2002 · Circulation · 941 citations
Background — Patent foramen ovale (PFO) is associated with stroke, but there are no randomized studies to evaluate the efficacy of antithrombotic therapies. Methods and Results — The PFO in Cryptog...
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
Bernhard Meier, Bindu Kalesan, Heinrich P. Mattle et al. · 2013 · New England Journal of Medicine · 902 citations
Closure of a patent foramen ovale for secondary prevention of cryptogenic embolism did not result in a significant reduction in the risk of recurrent embolic events or death as compared with medica...
PATENT FORAMEN OVALE IN YOUNG STROKE PATIENTS
Mark Webster, H. Smith, D. N. Sharpe et al. · 1988 · The Lancet · 826 citations
Reading Guide
Foundational Papers
Start with Lechat et al. (1988) for PFO prevalence in stroke; Mas et al. (2001) for risk with aneurysm; Homma et al. (2002) for medical therapy outcomes—these establish diagnostic and prognostic foundations (1652+941 citations).
Recent Advances
Study Mas et al. (2017) for closure superiority and Meier et al. (2013) for RCT comparisons in cryptogenic embolism; Handke et al. (2007) extends to older patients.
Core Methods
Contrast echocardiography with Valsalva for shunt detection (Lechat et al., 1988); RoPE scoring for cryptogenic attribution; TEE for aneurysm sizing (Mas et al., 2001); RCT endpoints of recurrent TIA/stroke (Mas et al., 2017).
How PapersFlow Helps You Research Paradoxical Embolism through Patent Foramen Ovale
Discover & Search
Research Agent uses searchPapers('paradoxical embolism PFO diving') to retrieve 500+ papers including Lechat et al. (1988); citationGraph maps Mas et al. (2001) clusters to 1353 citations; findSimilarPapers expands Meier et al. (2013) to closure RCTs; exaSearch queries 'PFO air embolism decompression'.
Analyze & Verify
Analysis Agent runs readPaperContent on Mas et al. (2017) to extract hazard ratios (HR 0.03 for closure); verifyResponse with CoVe cross-checks recurrence rates against Homma et al. (2002); runPythonAnalysis computes meta-analysis odds ratios from 5 RCTs using pandas; GRADE grades Mas et al. (2017) as high evidence for closure.
Synthesize & Write
Synthesis Agent detects gaps in diving-specific PFO data via contradiction flagging across Mirski et al. (2007) and Lechat et al. (1988); Writing Agent uses latexEditText for embolism flowcharts, latexSyncCitations for 20-paper bibliography, latexCompile for review drafts; exportMermaid diagrams PFO shunt mechanics.
Use Cases
"Meta-analyze PFO closure RCTs for stroke recurrence rates"
Research Agent → searchPapers + citationGraph → Analysis Agent → runPythonAnalysis (pandas meta-analysis of Mas 2017, Meier 2013) → outputs forest plot CSV with pooled RR 0.35.
"Draft LaTeX review on PFO paradoxical embolism in divers"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Lechat 1988, Mirski 2007) + latexCompile → outputs PDF with PFO risk table and citations.
"Find code for PFO shunt quantification from echocardiography papers"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo + githubRepoInspect → outputs Python scripts for bubble count analysis from contrast echo videos.
Automated Workflows
Deep Research workflow scans 50+ PFO papers via searchPapers → citationGraph → structured report with GRADE scores on closure vs. medical therapy (Mas et al., 2017). DeepScan applies 7-step CoVe to verify embolism prevalence in divers (Mirski et al., 2007). Theorizer generates hypotheses linking PFO size to air embolism risk from Lechat et al. (1988) clusters.
Frequently Asked Questions
What defines paradoxical embolism via PFO?
Venous thrombi or gas cross PFO into arterial circulation, detected by contrast echocardiography with right-to-left shunt (Lechat et al., 1988). Differs from orthograde embolism by venous origin.
What methods diagnose PFO-related embolism?
Transesophageal contrast echo with Valsalva grades shunts; TEE detects 90% PFOs missed by transthoracic (Lechat et al., 1988). MRI confirms multiorgan infarcts (Handke et al., 2007).
What are key papers on PFO stroke risk?
Lechat et al. (1988, 1652 citations) shows 40% prevalence in young strokes; Mas et al. (2001, 1353 citations) links aneurysm to 4x recurrence; Mas et al. (2017, 1108 citations) favors closure.
What open problems remain?
Optimal closure timing in divers; anticoagulation duration post-event; biomarkers for high-risk PFOs beyond size (Meier et al., 2013; Goldstein et al., 2014).
Research Cardiovascular and Diving-Related Complications with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Paradoxical Embolism through Patent Foramen Ovale with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers